The Excellence Awards celebrate the greatest achievements and innovations in the industry. The programme provides a platform to recognize the people and companies that are driving change.
Our programme is designed to highlight excellence within the sector by looking at a range of corporate activities including deals, business projects and company initiatives, both internal and in the community.
What is Innovation?
Innovation is the category with one of the widest scopes within the Excellence Awards as it looks at novel new approaches in every area, from the fruits of research and development to novel new business practices. What all the ranked entities have in common is the demonstration of new concepts not just within their own business but in the sector as a whole.
The category includes any projects that demonstrate an innovative approach to the market. The category crosses over with many of our other categories and can include new products, novel product features, new business practices, new marketing and sales strategies and more.
Is your company listed?
If you want to learn more about the Awards and the range of marketing materials and options available to promote your achievement then please get in touch with us or download the Media Pack:
Contact: Olga Kovalova – Olga.Kovalova@globaldata.com
Book a meeting with Olga – https://calendly.com/olga-kovalova
A clear theme for innovation during the research period has been the increased use of AI for a variety of different purposes. The most visible form has been its use for drug discovery and development with various companies using third party platforms or building their own tools to make the process faster and more efficient.
As well as discovering new treatments AI has also been utilised to study how existing drugs and substances can be repurposed and used to tackle disease. The technology is also being used to tackle widespread issues like superbugs and is being incorporated into a variety of medical devices.
Other forms of technology are also coming to the fore. Linked to the use of AI is the adoption by various pharmaceutical companies of quantum computing solutions for drug discovery and other tasks, with supercomputers set to become more common and be used for more varied tasks.
Elsewhere the other key theme is how the Covid-19 pandemic has acted as a catalyst for innovation in a variety of areas, from vaccine development to treatments as well as driving change in business practices such as IT and logistics.
This category includes companies that have utilised AI for a variety of purposes from drug development to medical devices.
This category includes companies that have demonstrated innovation in their business practices, whether it be improved organisation and logistics or new products and services.
This category includes companies that have demonstrated innovation in drug development and discovery and clinical trials and includes innovation both in the products themselves and the processes used to create them.
This category includes companies that have adopted innovative models for dealing with medical waste or improving their carbon footprint.
This category includes companies that have demonstrated innovation in genetic medicine.
This category includes companies that have developed innovative new technologies, from medical devices to quantum computing.
This category includes companies that have developed innovative new treatments.
This category includes companies that have demonstrated innovation in vaccine research, development and distribution.